Depletion of regulatory T cells increases T cell brain infiltration, reactive astrogliosis, and interferon-γ gene expression in acute experimental traumatic brain injury

被引:82
|
作者
Kraemer, Tobias J. [1 ]
Hack, Nathalia [1 ]
Bruehl, Till J. [2 ]
Menzel, Lutz [1 ]
Hummel, Regina [1 ]
Griemert, Eva-Verena [1 ]
Klein, Matthias [2 ,3 ]
Thal, Serge C. [1 ]
Bopp, Tobias [2 ,3 ]
Schaefer, Michael K. E. [1 ,3 ,4 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Anesthesiol, Langenbeckstr 1,Bld 505, D-55131 Mainz, Germany
[2] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Immunol, Langenbeckstr 1, D-55131 Mainz, Germany
[3] Johannes Gutenberg Univ Mainz, Res Ctr Immunotherapy FZI, Mainz, Germany
[4] Johannes Gutenberg Univ Mainz, Focus Program Translat Neurosci FTN, Mainz, Germany
关键词
Traumatic brain injury; Inflammation; Cytokines; Immune response; T cells; Astrocytes; Microglia; ISCHEMIC-STROKE; INFLAMMATION; SYSTEM; NEUROPROTECTION; ASTROCYTES; MOTOR; MICE; NEUROINFLAMMATION; PATHOPHYSIOLOGY; PROGRANULIN;
D O I
10.1186/s12974-019-1550-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Traumatic brain injury (TBI) is a major cause of death and disability. T cells were shown to infiltrate the brain during the first days after injury and to exacerbate tissue damage. The objective of this study was to investigate the hitherto unresolved role of immunosuppressive, regulatory T cells (Tregs) in experimental TBI. Methods "Depletion of regulatory T cell" (DEREG) and wild type (WT) C57Bl/6 mice, treated with diphtheria toxin (DTx) to deplete Tregs or to serve as control, were subjected to the controlled cortical impact (CCI) model of TBI. Neurological and motor deficits were examined until 5 days post-injury (dpi). At the 5 dpi endpoint, (immuno-) histological, protein, and gene expression analyses were carried out to evaluate the consequences of Tregs depletion. Comparison of parametric or non-parametric data between two groups was done using Student's t test or the Mann-Whitney U test. For multiple comparisons, p values were calculated by one-way or two-way ANOVA followed by specific post hoc tests. Results The overall neurological outcome at 5 dpi was not different between DEREG and WT mice but more severe motor deficits occurred transiently at 1 dpi in DEREG mice. DEREG and WT mice did not differ in the extent of brain damage, blood-brain barrier (BBB) disruption, or neuronal excitotoxicity, as examined by lesion volumetry, immunoglobulin G (IgG) extravasation, or calpain-generated alpha II-spectrin breakdown products (SBDPs), respectively. In contrast, increased protein levels of glial fibrillary acidic protein (GFAP) and GFAP+ astrocytes in the ipsilesional brain tissue indicated exaggerated reactive astrogliosis in DEREG mice. T cell counts following anti-CD3 immunohistochemistry and gene expression analyses of Cd247 (CD3 subunit zeta) and Cd8a (CD8a) further indicated an increased number of T cells infiltrating the brain injury sites of DEREG mice compared to WT. These changes coincided with increased gene expression of pro-inflammatory interferon-gamma (Ifng) in DEREG mice compared to WT in the injured brain. Conclusions The results show that the depletion of Tregs attenuates T cell brain infiltration, reactive astrogliosis, interferon-gamma gene expression, and transiently motor deficits in murine acute traumatic brain injury.
引用
收藏
页数:14
相关论文
共 42 条
  • [41] Genetically modified NT2N human neuronal cells mediate long-term gene expression as CNS grafts in vivo and improve functional cognitive outcome following experimental traumatic brain injury
    Watson, DJ
    Longhi, L
    Lee, EB
    Fulp, CT
    Fujimoto, S
    Royo, NC
    Passini, MA
    Trojanowski, JQ
    Lee, VMY
    McIntosh, TK
    Wolfe, JH
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2003, 62 (04): : 368 - 380
  • [42] Immune system regulation of transgene expression in the brain 2: Differential increase of mRNAs encoding for interferon-regulated, chemokine, and T-cell genes during either innate acute or chronic systemic adaptive immune responses to first generation adenoviral vectors
    Zirger, JM
    Barcia, C
    Liu, CY
    Puntel, M
    Sitia, G
    Guidotti, L
    Mitchell, N
    Campbell, I
    Castro, MG
    Lowenstein, PR
    MOLECULAR THERAPY, 2004, 9 : S390 - S391